Xinji Medical Information Consulting (Shanghai) Co., Ltd. was registered in Shanghai Administration for Industry and Commerce on June 5438+February 5, 2009. The legal representative is Jun Yan, whose business scope includes medical information consultation and related technical consultation (except medical treatment), marketing planning consultation (except advertising) and so on.
Pharmaceutical Group Company is making every effort to promote the five platforms of the Group-modern logistics distribution integrated operation platform, Industry-University-Research integrated scientific and technological innovation platform, national drug retail chain network, national narcotic drug distribution network, national biological product marketing and cold chain distribution network, national medical device consumables product distribution network, scientific instruments and medical devices, medical research and engineering design.
The international operation of medicine and the all-round development of overseas industries, medical exhibitions and media, and medical and health industries constitute an innovative enterprise with medical and health industry as its core competitiveness. Pharmaceutical Group has a distribution network covering 365,438+0 provinces, autonomous regions and municipalities directly under the Central Government and 30 distribution centers in line with international standards. Is the largest biological R&D and production enterprise in China.
It has undertaken more than 80% of the production tasks of the national immunization program vaccine. The group has established production bases and medicinal materials bases for biopharmaceuticals, narcotic psychotropic drugs, anti-infective drugs, anti-tumor drugs, cardiovascular and cerebrovascular drugs and respiratory drugs, and has the strongest applied drug research institutions and engineering design institutes in China. 20 10 China pharmaceutical group co., ltd was awarded as a national innovative enterprise.